Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Spencer, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spencer, R. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1996) 37, 295-301
© 1996 The British Society for Antimicrobial Chemotherapy

research-article

An 8 year Microbe Base survey of the epidemiology, frequency and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom

Robert C. Spencer

Public Health Laboratory, Level 8, Bristol Royal Infirmary Marlborough Street, Bristol BS2 8HW, UK

Received 27 June 1995; returned 15 August 1995; accepted 18 September 1995

Over the last 8 years selected United Kingdom hospitals have contributed antimicrobial susceptibility data to a central data base called Microbe Base. During that period, data on 1,000,067 isolates have been collected, including 29,425 isolates of Pseudomonas aeruginosa. The present study focused on the epidemiology, frequency and antibiotic susceptibility of P. aeruginosa isolates (17,440) from hospitalised patients. In such patients P. aeruginosa was predominant in general surgery (20%), care of the elderly (18%), general medicine (13%), and paediatrics and neonates (10%). Ninety-five per cent of P. aeruginosa were susceptible in vitro to ceftazidime compared with 93% for piperacillin, 92% for gentamicin, 90% for ciprofloxacin, and 89% for imipenem. Excluding susceptibility data reported in 1991, there was no change in the susceptibility pattern of P. aeruginosa throughout the study period.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.